Antitumor Agent For Thyroid Cancer

Patent No. EP2036557 (titled "Antitumor Agent For Thyroid Cancer") was filed by Eisai R&D Management on May 17, 2007. The application was issued on Oct 21, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UK TRADING MYLANJul 21, 2016GILL JENNINGS & EVERY
ACTAVIS GROUP PTC EHFJul 18, 2016GILLARD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2036557

EISAI R&D MANAGEMENT
Application Number
EP07743994A
Filing Date
May 17, 2007
Status
Revoked
May 4, 2018
Publication Date
Oct 21, 2015